Since 2007, Meisys has been a scientific consultancy firm which focuses on businesses in the health sector and specialises in creating value for our clients in technological and scientific fields, offering appropriate solutions for their business needs.
WHAT WE DO
We rely on technical support from an interdisciplinary team of doctors, pharmacists and health science graduates and we are led by professionals with proven experience, from Spanish and multinational pharmaceutical companies.
At Meisys, we consider training and the updating of different work areas that affect both us and our customers to be vital. So we offer various training courses both open and in company.
Constant training is therefore an important aspect of our business, and we rely on the collaboration of recognised experts in the fields of training and other areas that can affect the pharmaceutical industry
What we offer
Los derechos de autor protegen la propiedad intelectual, es decir, garantizan el reconocimiento para explotar comercialmente, divulgar o reproducir una obra en exclusiva.
El pasado mes de junio, el Sistema Español de Farmacovigilancia, coordinado por la AEMPS, publicó un resumen de las notificaciones de Sospechas de Reacciones Adversas (SAR) a medicamentos durante el 2021: en total hubo 81.447 notificaciones de SAR tras recibir un medicamento, incrementándose la notificación con respecto a 2020 un 161%.